Key result
This review describes the underlying causes, detection methods, pre-participation guidelines, and emerging therapies for sudden cardiac death in athletes.
This review outlines the causes, detection methods, and screening guidelines for sudden cardiac death in athletes.
Synthesizes SCD knowledge for athlete screening; leaves open prospective validation of emerging therapies before practice change.
Sudden cardiac death in athletes, although relatively uncommon, is a well-recognized condition generally associated with some congenital abnormalities. It, however, continues to be of vast interest to the public as athletes are seen as a distinct group of individuals who are especially able to tolerate more intense physical activities than the general population. Obviously, intense activities predispose susceptible athletes to sudden cardiac death, hence the importance of pre-participation screening tests. As the cost of healthcare continues to be on the rise, there will be increasing difficulty justifying a nation-wide method of screening cost-effectively. This article is intended to describe the possible underlying causes of sudden cardiac death discovered thus far, as well as methods for detection, pre-participation guidelines, and emerging therapy.
No takes yet. Share an insight, caveat, or question.
Lorvidhaya et al. (2003) conducted a review in Sudden cardiac death in athletes. This review describes the underlying causes, detection methods, pre-participation guidelines, and emerging therapies for sudden cardiac death in athletes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: